HemOnc Today has published a nice article discussing what responsibility the oncologist has in informing the patient about his/her fertility risks and potential for preservation. The article cites the most recent American Society of Clinical Oncologists (ASCO) meeting, which found that only approximately 25% of oncologists refer their patients for fertility preservation. Furthermore, less than 40% of oncologists were aware of ASCO's recommendations for patient guidance and navigation regarding fertility preservation. The article also discusses benefits and disadvantages of current fertility preservation methods available for men and women, including gamete cryopreservation, embryo creation and freezing, and ovarian tissue banking.
To overcome these obstacles in doctor-patient communication, the article suggests that oncologists seek information from the Oncofertility Consortium's Physician hotline and be very clear in their recommendations to patients, as these can be incredibly influential in the patient's ultimate decisions about fertility preservation.
The contents of the Oncofertility Consortium Blog are for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
965 Wilson Road, Room A626B
East Lansing, MI 48824-1316
Phone: 1 (517) 884 8848
Ownership of this website has been transferred from Northwestern University to Michigan State University. Please note that some site information may be inaccurate while adjustments to reflect this organizational change are made.